- Home
- SGMA vs BCLI Comparison
SGMA vs BCLI Comparison
Compare SGMA & BCLI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SGMA
- BCLI
- Stock Information
- Founded
- SGMA 1993
- BCLI 2000
- Country
- SGMA United States
- BCLI United States
- Employees
- SGMA N/A
- BCLI N/A
- Industry
- SGMA Electrical Products
- BCLI Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SGMA Technology
- BCLI Health Care
- Exchange
- SGMA Nasdaq
- BCLI Nasdaq
- Market Cap
- SGMA 6.2M
- BCLI 7.7M
- IPO Year
- SGMA 1994
- BCLI N/A
- Fundamental
- Price
- SGMA $2.96
- BCLI $1.12
- Analyst Decision
- SGMA
- BCLI Strong Buy
- Analyst Count
- SGMA 0
- BCLI 1
- Target Price
- SGMA N/A
- BCLI $30.00
- AVG Volume (30 Days)
- SGMA 1.2M
- BCLI 3.4M
- Earning Date
- SGMA 03-14-2025
- BCLI 05-15-2025
- Dividend Yield
- SGMA N/A
- BCLI N/A
- EPS Growth
- SGMA N/A
- BCLI N/A
- EPS
- SGMA N/A
- BCLI N/A
- Revenue
- SGMA $311,706,094.00
- BCLI N/A
- Revenue This Year
- SGMA N/A
- BCLI N/A
- Revenue Next Year
- SGMA N/A
- BCLI N/A
- P/E Ratio
- SGMA N/A
- BCLI N/A
- Revenue Growth
- SGMA N/A
- BCLI N/A
- 52 Week Low
- SGMA $0.96
- BCLI $0.72
- 52 Week High
- SGMA $6.47
- BCLI $8.25
- Technical
- Relative Strength Index (RSI)
- SGMA 79.34
- BCLI 47.37
- Support Level
- SGMA $1.10
- BCLI $1.00
- Resistance Level
- SGMA $2.99
- BCLI $1.92
- Average True Range (ATR)
- SGMA 0.12
- BCLI 0.17
- MACD
- SGMA 0.14
- BCLI -0.01
- Stochastic Oscillator
- SGMA 98.41
- BCLI 13.04
About SGMA SigmaTron International Inc.
Sigmatron International Inc is an independent provider of electronic manufacturing services (EMS). It provides manufacturing and assembly services ranging from the assembly of individual components to the assembly and testing of box-build electronic products. The company manufactures products like printed circuit board assemblies, electro-mechanical subassemblies, and completely assembled (box-build) electronic products which are incorporated into finished products and sold in various industries, particularly industrial electronics, consumer electronics, and life sciences. In some instances, it manufactures and assembles the completed finished product for its customers. Geographically, the company derives maximum revenue from Mexico and the rest from the United States, China, and Vietnam.
About BCLI Brainstorm Cell Therapeutics Inc.
Brainstorm Cell Therapeutics Inc is a biotechnology company. The company is developing novel adult stem cell therapies for debilitating neurodegenerative disorders such as Amyotrophic Lateral Sclerosis (ALS, also known as Lou Gehrig's disease), Progressive Multiple Sclerosis (PMS), and Parkinson's disease (PD). Brainstorm's NurOwn, its proprietary process for the propagation of Mesenchymal Stem Cells (MSC) and differentiation into neurotrophic factor-(NTF) secreting cells (MSC-NTF), and their transplantation at, or near, the site of damage, offers the hope of more effectively treating neurodegenerative diseases.